^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Auraza (chiauranib)

    i
    Company:
    Chipscreen
    Drug class:
    VEGFR inhibitor, CSF-1R inhibitor, Aurora kinase B inhibitor
    Related drugs:
    Apply
    A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer (NCT05505825)
    Phase 1/2
    Akeso
    Active, not recruiting
    Last update posted :
    05/24/2024
    Initiation :
    08/26/2022
    Primary completion :
    12/01/2024
    Completion :
    01/01/2025
    ATRX
    |
    ATRX mutation
    |
    Kaitanni (cadonilimab) • Auraza (chiauranib)
    A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC (NCT05336721)
    Phase 2
    Chipscreen Biosciences, Ltd.
    Recruiting
    Last update posted :
    04/20/2022
    Initiation :
    11/05/2021
    Primary completion :
    03/15/2024
    Completion :
    08/09/2024
    HER-2 • ER • PGR
    |
    ER negative • PGR negative
    |
    capecitabine • Auraza (chiauranib)